Insulet (PODD) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $164.48 +2.94%
Revenue Growth %: +21.5%
Financial Fact:
Other expense, net: -5.37M
Today's EPS Names:
CRMT, More
Revenue Growth %: +21.5%
Financial Fact:
Other expense, net: -5.37M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q2 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $177.1 million versus the consensus estimate of $163.66 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA: classifies Insulet OmniPod pods recall as Class I due to serious injury risk
- RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform
- FactSet Research Systems (FDS) PT Raised to $253 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
